Compare Stocks → The “Perfect Storm” for Gold (From Gold Safe Exchange) (Ad) Compare stocks and their fundamentals, performance, price, and technicals. Use this free stock comparison tool to evaluate companies based on their analyst ratings, book value, debt, dividend, MarketRank, news sentiment, price performance, profitability, and more. Enter up to ten stock symbols separated by a comma or space (ex. BAC, JPM, WFC, C, GS). Comparison Ideas Agriculture StocksAirline StocksApparel StocksArtificial Intelligence StocksAutomotive StocksBank StocksBitcoin StocksBlockchain StocksCanadian StocksCannabis StocksCasino StocksChatGPT StocksChinese StocksCloud Storage StocksCoronavirus Therapeutics StocksCryptocurrency StocksCybersecurity StocksDefense StocksDividend StocksDow 30 StocksEcommerce StocksElectric Vehicles StocksEnergy StocksEntertainment StockseSports StocksEV Charging StocksFertilizer StocksGold StocksGrocery StocksGrowth StocksHealthcare StocksHigh Dividend StocksHome Office StocksHotel StocksLarge Cap StocksLeisure StocksLithium StocksMagnificent Seven StocksMATANA StocksMega Cap StocksMeme StocksMetaverse StocksMid Cap StocksMining StocksMusic Industry StocksNanotechnology StocksNFT StocksOil StocksOutdoor Activities StocksPharmaceutical StocksRenewable Energy StocksRestaurant StocksRetail StocksSemiconductor StocksSocial Media StocksSolar StocksSpace StocksStay-At-Home StocksTechnology StocksTelecom StocksToy StocksUtility StocksVaccine StocksVideo Game StocksVirtual Reality StocksWallStreetBets Stocks Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare Share Comparison Share Comparison NYSE:AGENASDAQ:GPCVE:KDINYSE:PML Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Stocks - Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeAGEAgeX Therapeutics$3.23$11.07▼$35.71$11.99M1.183,849 shs3,700 shsGPGreenPower Motor$1.76+1.7%$2.05$1.62▼$6.05$43.98M3.448,314 shs46,969 shsKDIKennady DiamondsC$2.95-1.7%C$2.95C$2.45▼C$3.86C$150.19MN/A39,418 shs1,000 shsPMLPIMCO Municipal Income Fund II$8.30-0.1%$8.47$6.92▼$9.45N/AN/A174,356 shs129,428 shsThe Best High-Yield Dividend Stocks for 2024Looking to generate income with your stock portfolio? Use these ten stocks to generate a safe and reliable source of investment income.Get This Free ReportPrice PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceAGEAgeX Therapeutics0.00%0.00%-23.61%+4,340.00%+2,916.30%GPGreenPower Motor+4.73%+1.14%-8.29%-37.01%-34.44%KDIKennady Diamonds0.00%0.00%0.00%0.00%0.00%PMLPIMCO Municipal Income Fund II-1.07%-0.72%-1.54%+2.47%-7.46%Biden’s $374B Giveaway Into This Sector (Ad)Biden’s Climate Bill Could Send Your Retirement Accounts Soaring – Or Diving See what this $374B giveaway could mean for your retirement right hereClick here for the full storyMarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationAGEAgeX TherapeuticsN/AN/AN/AN/AN/AN/AN/AN/AGPGreenPower Motor2.8452 of 5 stars3.45.00.00.02.51.70.6KDIKennady DiamondsN/AN/AN/AN/AN/AN/AN/AN/APMLPIMCO Municipal Income Fund IIN/AN/AN/AN/AN/AN/AN/AN/AAnalyst RatingsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceAGEAgeX TherapeuticsN/AN/AN/AN/AGPGreenPower Motor2.75Moderate Buy$5.00184.09% UpsideKDIKennady DiamondsN/AN/AN/AN/APMLPIMCO Municipal Income Fund IIN/AN/AN/AN/ACurrent Analyst RatingsLatest AGE, GP, KDI, and PML Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails4/1/2024GPGreenPower MotorRoth MkmSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetBuy ➝ Buy$7.00 ➝ $3.00(Data available from 4/19/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookAGEAgeX Therapeutics$140K0.00N/AN/A($16.07) per share0.00GPGreenPower Motor$39.70M1.11N/AN/A$1.11 per share1.59KDIKennady DiamondsN/AN/AN/AN/AN/AN/APMLPIMCO Municipal Income Fund II$62.25MN/AN/AN/AN/AN/AProfitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateAGEAgeX Therapeutics-$14.80M-$13.03N/AN/AN/A-10,424.65%N/A-120.90%5/13/2024 (Estimated)GPGreenPower Motor-$15.04M-$0.63N/AN/AN/A-31.47%-66.07%-27.92%7/12/2024 (Estimated)KDIKennady DiamondsN/AN/A0.00∞N/AN/AN/AN/AN/APMLPIMCO Municipal Income Fund IIN/AN/A0.00∞N/AN/AN/AN/AN/ALatest AGE, GP, KDI, and PML EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails2/13/202412/31/2023GPGreenPower Motor-$0.14-$0.19-$0.05-$0.19$12.00 million$8.16 million DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthAGEAgeX TherapeuticsN/AN/AN/AN/AN/AGPGreenPower MotorN/AN/AN/AN/AN/AKDIKennady DiamondsN/AN/AN/AN/AN/APMLPIMCO Municipal Income Fund II$0.475.66%N/AN/AN/ALatest AGE, GP, KDI, and PML DividendsAnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date4/1/2024PMLPIMCO Municipal Income Fund IIMonthly$0.03955.64%4/10/20244/11/20245/1/20243/1/2024PMLPIMCO Municipal Income Fund IIMonthly$0.03955.53%3/8/20243/11/20244/1/20242/1/2024PMLPIMCO Municipal Income Fund IIMonthly$0.03955.52%2/9/20242/12/20243/1/2024(Data available from 1/1/2013 forward)DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioAGEAgeX TherapeuticsN/A0.130.36GPGreenPower Motor0.261.860.40KDIKennady DiamondsN/AN/AN/APMLPIMCO Municipal Income Fund IIN/AN/AN/AOwnershipInstitutional OwnershipCompanyInstitutional OwnershipAGEAgeX Therapeutics12.50%GPGreenPower Motor1.69%KDIKennady DiamondsN/APMLPIMCO Municipal Income Fund IIN/AInsider OwnershipCompanyInsider OwnershipAGEAgeX Therapeutics6.50%GPGreenPower Motor28.10%KDIKennady DiamondsN/APMLPIMCO Municipal Income Fund IIN/AMiscellaneousCompanyEmployeesShares OutstandingFree FloatOptionableAGEAgeX Therapeutics51.08 million1.01 millionNot OptionableGPGreenPower Motor11224.99 million17.97 millionNot OptionableKDIKennady DiamondsN/A50.91 millionN/ANot OptionablePMLPIMCO Municipal Income Fund IIN/AN/AN/ANot OptionableAGE, GP, KDI, and PML HeadlinesSourceHeadlinePimco Closed-End Funds Declare Monthly Common Share Distributionsglobenewswire.com - March 1 at 5:16 PMPML: The Macro-Environment Keeps Pressuring This Optionmsn.com - September 20 at 5:50 PMPIMCO Municipal Income Fund II declares $0.0395 dividendmsn.com - February 9 at 2:22 PMPMF And PMX: Comparing 2 PIMCO Muni CEFsseekingalpha.com - July 2 at 3:27 AMPIMCO Municipal Income Fund II declares $0.059 dividendseekingalpha.com - February 7 at 3:27 PMNew MarketBeat Followers Over TimeMedia Sentiment Over TimeTop Headlines3 Value Stocks Too Small For Buffett’s PortfolioMarch 28, 2024 12:16 PMView 3 Value Stocks Too Small For Buffett’s Portfolio5 Stocks in the Current Bull Market with Upside to ComeApril 5, 2024 10:14 AMView 5 Stocks in the Current Bull Market with Upside to Come2 Data Storage Device Stocks Thriving From the AI BoomApril 2, 2024 7:25 AMView 2 Data Storage Device Stocks Thriving From the AI BoomMicron Technology Results Proves AI is Driving Storage DemandMarch 26, 2024 7:35 AMView Micron Technology Results Proves AI is Driving Storage Demand4 Overbought Household Names, Time for a Pullback?March 25, 2024 9:35 AMView 4 Overbought Household Names, Time for a Pullback?All Headlines Company DescriptionsAgeX TherapeuticsNYSE:AGEAgeX Therapeutics, Inc., a biotechnology company, focuses on the development and commercialization of novel therapeutics targeting human aging and degenerative diseases in the United States. The company's lead cell-based therapeutic candidates in development include AGEX-BAT1, a cell therapy product candidate for the treatment of various age-related metabolic disorders, such as Type II adult-onset diabetes and obesity; and AGEX-VASC1, a cell-based therapy to restore vascular support in aged ischemic tissues, such as peripheral vascular disease and ischemic heart disease. Its lead small molecule drug-based therapeutic candidate for scarless wound repair in discovery is AGEX-iTR1547, a drug-based formulation; and lead biologic candidate for induced tissue regeneration is AGEX-iTR1550 (Renelon), a gene delivery technology. AgeX Therapeutics, Inc. has a research collaboration with the University of California at Irvine to develop cellular therapies to treat neurological disorders and diseases. The company was incorporated in 2017 and is based in Alameda, California.GreenPower MotorNASDAQ:GPGreenPower Motor Company Inc. designs, manufactures, and distributes electric vehicles for commercial markets in the United States and Canada. The company offers commercial vehicles for delivery, public transit, schools, vanpools, micro-transit, shuttles, and other; and passenger, student, low floor transit, and cargo transportation. It leases its vehicles to customers. GreenPower Motor Company Inc. was founded in 2010 and is headquartered in Vancouver, Canada.Kennady DiamondsCVE:KDIKennady Diamonds Inc. engages in the discovery, evaluation, exploration, and development of diamond properties in Canada. It owns a 100% interest in the Kennady North diamond project that comprises 22 federal leases and 58 mineral claims covering an area of 67,164.17 hectares located in the north-east of Yellowknife, Northwest Territories. The company was incorporated in 2012 and is based in Toronto, Canada.PIMCO Municipal Income Fund IINYSE:PMLPIMCO Municipal Income Fund II is a closed ended fixed income mutual fund launched and managed by Allianz Global Investors Fund Management LLC. The fund is co-managed by Pacific Investment Management Company LLC. It invests in fixed income markets. The fund invests in stocks of companies operating across diversified sectors. It seeks to invest primarily in municipal bonds, variable rate notes, variable rate demand notes, and U.S. treasury bills. PIMCO Municipal Income Fund II was formed on June 28 2002 and is domiciled in United States. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.